Assessment report for GLP-1 based therapies (Article 53 procedure) EMA
When we leverage absorption enhancers (SNAC technology), it protect the peptide from gastric degradation and enables intestinal uptake
GLP-1 injections, including medications like semaglutide and tirzepatide, are transforming the way people approach weight loss and metabolic health
That is what makes it different from most topical treatments, which address the surface of a specific area, or from peptides like BPC-157, which address a specific type of tissue damage
Meanwhile, inulin treatment increased expression of chemokines (CCL4, CCL8), inflammatory vesicle-related genes (TLR3, TLR7) and antigen presentation-related genes (CD40, Stat1, ICOS), induced anti-tumor immunity, and inhibited the growth of colon tumors
Safety considerations also warrant attention